2017年12月2日,

22:58美国东部时间2017年12月1 | BioPortfolio报告总结埃斯佩兰斯制药公司希望是一个肿瘤产品的开发人员。公司开发和分发药物治疗癌症。其产品包括EP100肽共轭,EP200肽共轭,EP300肽配合和抗体药物配合。埃斯佩兰斯发展药物治疗卵巢癌,乳腺癌、子宫内膜癌、前列腺癌、胰腺癌、实体肿瘤和血液癌症。该公司使用阳离子裂解肽技术平台发展的药物。开发有针对性的癌症疗法称为膜破坏肽杀死癌细胞。埃斯佩兰斯总部位于休斯顿,德克萨斯州,美国。埃斯佩兰斯制药公司药品医疗交易和联盟为您提供全面的数据和趋势分析公司并购的MAs,伙伴关系和融资。报告提供详细信息的并购,股票/债券发行、私募股权、风险融资和合作公司交易记录的一个五年计划。报告提出了详细的比较数据,交易数量和他们的价值分为交易类型,界别分组和地区。 GlobalData derived the data presented in this report from proprietary inhouse Pharma eTrack deals database, and primary and secondary research. Scope Financial Deals Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. Deals by Type Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. Deals by Region Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. Deals by Subsector Chart and table showing information on the number of deals and value reported by the company, by subsector. Major Deals Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's major public companies key financial metrics and ratios. Business Description A brief description of the company's operations. Key Employees A list of the key executives of the company. Important Locations and Subsidiaries A list and contact details of key centers of operation and subsidiaries of the company. Key Competitors A list of the key competitors of the company. Key Recent Developments A brief on recent news about the company. Reasons to Buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company's operations to identify potential customers and suppliers. The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay uptodate on the major developments affecting the company Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company. Related Biotechnology, Pharmaceutical and Healthcare News